Pathophysiology of rheumatoid arthritis: Split or lump?

Arthritis and Rheumatism

Volumn 58, Issue 10, 2008, Pages 2925-2927

  Boers, Maarten ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28-JOINT ASSESSMENT; ECHOGRAPHY; EDITORIAL; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SWELLING; SYNOVITIS;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; JOINTS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 54949147223     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23944     Document Type: Editorial

References (16)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
2. Welsing PM, van Gestel AM, Swinkels HL, Lambertus AL, Kiemeney LA, et al. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
3. Boers M, Kostense PJ, Verhoeven AC, van der Linden S, for the COBRA Trial Group. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum 2001;44:2242-6.
4. Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996;35:1263-8.
5. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004;50:36-42.
6. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis: a prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
7. Kirwan JR. Systemic low-dose glucocorticoid treatment in rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:389-403, ix-x.
8. Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al, for the ATTRACT Study Group. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy study. Arthritis Rheum 2005;52:1020-30.
9. Kirwan JR. The synovium in rheumatoid arthritis: evidence for (at least) two pathologies [editorial]. Arthritis Rheum 2004;50:1-4.
10. Boers M, for the COBRA Study Group. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Arthritis Rheum 2001;44:2703-4.
11. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008;58:2958-67.
12. Pinals RS, Masi AT, Larsen RA and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
13. Prevoo ML, van Gestel AM, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the Disease Activity Score. Br J Rheumatol 1996;35:1101-5.
14. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006;54:3761-73.
15. Boers M, Brooks P, Strand V, Tugwell P. The OMERACT Filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
16. Wells G, Boers M, Tugwell P, for the MDA Working Group. Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity. Clin Exp Rheumatol 2006;24 Suppl 43:S52-9.